Most Cancer Patients Resume Treatment After ICU, But Half Abandon Original Plan
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
A new systematic review and meta-analysis of 20 studies finds that 61 percent of cancer patients resume some anticancer treatment ...
A new systematic review finds venlafaxine has solid evidence for treating cancer-related hot flashes but says its potential as a ...
A deep learning model that reads multiregional contrast-enhanced breast MRI can predict whether chemotherapy has completely cleared the axillary lymph ...
A new review in Supportive Care in Cancer reframes chemotherapy-induced thrombocytopenia as a dual destruction of megakaryocytes and the bone ...
A Norwegian study of 115 head and neck cancer patients shows that six plasma proteins measured at diagnosis predict ten-year ...
A sweeping search of international clinical trial registries has revealed just how thin the evidence base is for one of ...
A prospective Hungarian study of 50 breast cancer patients found the PAXMAN scalp cooling system preserved hair in 69% of ...
A new study shows that the microRNA-197-3p molecule, which is depleted in ovarian cancer, directly suppresses the collagen protein COL4A6 ...
A nationwide analysis of 8,104 Hungarian patients treated from 2013 to 2022 shows median survival of just 9.3 months with ...
A 16-year analysis of 361 overseas new drugs shows China's regulatory reforms cut approval lag and reimbursement delays, but biologics, ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine